Skip to main content
Article
Vaccination of Women with Metastatic Breast Cancer, Using a Costimulatory Gene (CD80)-Modified, HLA-A2-Matched, Allogeneic, Breast Cancer Cell Line: Clinical and Immunological Results
Human Gene Therapy (2003)
  • Annemieke Dols, Providence Portland Medical Center
  • John W. Smith, Loyola University Chicago
  • Sybren L. Meijer, Providence Portland Medical Center
  • Bernard A. Fox, Providence Portland Medical Center
  • Hong-Ming Hu, Providence Portland Medical Center
  • Edwin Walker, Providence Portland Medical Center
  • Sidney Rosenheim
  • Tarsem Moudgil, Providence Portland Medical Center
  • Teri Doran, Providence Portland Medical Center
  • William Wood, Providence Portland Medical Center
  • Mark Seligman
  • W. Gregory Alvord, National Institutes of Health
  • Deric Schoof, Providence Portland Medical Center
  • Walter J. Urba, Providence Portland Medical Center
Publication Date
July 20, 2003
DOI
10.1089/104303403322124828
Citation Information
Annemieke Dols, John W. Smith, Sybren L. Meijer, Bernard A. Fox, et al.. "Vaccination of Women with Metastatic Breast Cancer, Using a Costimulatory Gene (CD80)-Modified, HLA-A2-Matched, Allogeneic, Breast Cancer Cell Line: Clinical and Immunological Results" Human Gene Therapy Vol. 14 Iss. 11 (2003) p. 1117 - 1123
Available at: http://works.bepress.com/walter-urba/215/